Insider Trades of NELSEN ROBERT Information

Click on the column header to resort ascending (▲) or descending (▼).

Individual Insider Trades

Company Relation Last Date ▲ Type Tran OwnerType Shares Traded Last Price Shares Held
AGIOS PHARMACEUTICALS INC Director 07/29/2013 Form 4 Acquisition (Non Open Market) indirect 3,860,738 0 3,860,738
FATE THERAPEUTICS INC Director 10/04/2013 Form 4 Acquisition (Non Open Market) indirect 1,639,855 6 1,639,855
FATE THERAPEUTICS INC Director 10/04/2013 Form 4 Buy indirect 833,333 6 2,473,188
KYTHERA BIOPHARMACEUTICALS INC Director 03/20/2014 Form 4 Disposition (Non Open Market) indirect 315,861 0 1,789,879
KYTHERA BIOPHARMACEUTICALS INC Director 03/20/2014 Form 4 Acquisition (Non Open Market) direct 1,175 0 1,175
AGIOS PHARMACEUTICALS INC Director 06/23/2014 Form 4 Disposition (Non Open Market) indirect 386,074 0 3,474,664
AGIOS PHARMACEUTICALS INC Director 06/23/2014 Form 4 Acquisition (Non Open Market) direct 2,230 0 2,230
KYTHERA BIOPHARMACEUTICALS INC Director 06/27/2014 Form 4 Disposition (Non Open Market) indirect 156,996 0 1,632,883
KYTHERA BIOPHARMACEUTICALS INC Director 06/27/2014 Form 4 Acquisition (Non Open Market) direct 584 0 1,759
SAGE THERAPEUTICS, INC. Director 07/23/2014 Form 4 Acquisition (Non Open Market) indirect 4,249,389 0 4,249,389
KYTHERA BIOPHARMACEUTICALS INC Director 08/14/2014 Form 4 Disposition (Non Open Market) indirect 210,574 0 1,422,309
KYTHERA BIOPHARMACEUTICALS INC Director 08/14/2014 Form 4 Acquisition (Non Open Market) direct 783 0 2,542
JUNO THERAPEUTICS, INC. Director 12/23/2014 Form 4 Acquisition (Non Open Market) indirect 10,455,375 0 11,552,390
SAGE THERAPEUTICS, INC. Director 01/14/2015 Form 4 Disposition (Non Open Market) indirect 1,062,345 0 3,187,044
SAGE THERAPEUTICS, INC. Director 01/14/2015 Form 4 Acquisition (Non Open Market) direct 6,135 0 6,135
BELLEROPHON THERAPEUTICS, INC. Director 02/12/2015 Form 4 Disposition (Non Open Market) indirect 752,994 0
BELLEROPHON THERAPEUTICS, INC. Director 02/12/2015 Form 4 Acquisition (Non Open Market) indirect 752,994 0 752,994
AGIOS PHARMACEUTICALS INC Director 02/19/2015 Form 4 Disposition (Non Open Market) indirect 386,074 0 3,088,590
AGIOS PHARMACEUTICALS INC Director 02/19/2015 Form 4 Acquisition (Non Open Market) direct 2,230 0 4,460
BELLEROPHON THERAPEUTICS, INC. Director 02/19/2015 Form 4 Buy indirect 212,666 12 1,718,654

Create your free portfolio